CTRI/2022/09/046079尚未招募2/3 期
Clinical evaluation of the effect of panchavalkal arka in kaphaja yoni vyapat(vulvovaginal candidiasis)
SRI DHARMASHALA MANJUNATHESWARA COLLEGE OF AYURVEDA AND HOSPITAL1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年3月10日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Major symptoms like curdy white discharge, vulval and vaginal itching should be cured.
研究概览
简要总结
This study is an open labeled single arm clinical trial to evaluate the effect of panchavalkal arka in 30 patients with Kaphaja yoni vyapat (vulvo-vaginal candidiasis).The study will be conducted at in/out patient department of prasuti tantra and stree roga in Sri Dharmsthala Manjunatheswara ayurveda hospital Hassan, karnataka.Patients will be advised to wash vulva with 10 ml panchavalkal arka diluted with 100 ml distilled lukewarm water twice a day for 7 days and assessment will be done at baseline,follow up on 7th and 15th day .
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Married women 2.Subjects fulfilling diagnostic criteria and having local signs and symptoms of kaphaja yoni vyapat as described in texts such as shweta and picchilasrava , yoni kandu and alpa vedana 3.wet vaginal smear postive for candida albicans or microscopically positive for pseudohyphea.
排除标准
- •1.Pregnant and lactating women 2.subjects positive for HIV,VDRL,HBsAG 3.Systemic diseases like diabets mellitus 4.Subjects on hormonal medications like contraception or regulation of menstruation 5.Subjects who have had anti fungal coverage within 1 month or corticosteriods for less than past 6 months.
结局指标
主要结局
Major symptoms like curdy white discharge, vulval and vaginal itching should be cured.
时间窗: Assessment will be done at baseline,follow up on 7th and 15 th day.Vaginal smear will be repeated on 15 th day for result.
次要结局
- Other symptoms like backache,pain during coitus should also be reduced.(15 days)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal CancerAdvanced Colorectal CancerNCT05364489The First Affiliated Hospital of Zhengzhou University20
招募中
1 期
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid TumorsAdvanced Malignant Solid TumorsNCT06728189Peking University Cancer Hospital & Institute13
尚未招募
1 期
A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCCNCT06870279RenJi Hospital28
招募中
1 期
U87 CAR-T in Patients With Advanced Head and Neck TumorsNasopharynx CancerHead and Neck CancerNCT06614686Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd20
招募中
1 期
Clinical Study of U32 in Patients With Acute Myeloid LeukemiaNCT07036250Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd20